Peptide record

TPDB45605

Antiviral standard
34 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45605
Antiviral
Anti-infective peptides
DRAVP 2.0 Peptipedia
standard
No
A 34-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0 and Peptipedia, with an available 3D structural model.
Sequence
QEGISRFKICPYHWYKQHMSLLFRRYYHKLDSII
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C204H303N55O48S2
ANTV
IY
4358.11
9.95
9
2
15
+4
1.93
-0.585
80.29
Mammalian: 0.8 hour Yeast: 10 min E.coli: >10 hour
11460
2.63
10
Residue Composition
number
0
A
3
R
0
N
1
D
1
C
1
E
2
Q
1
G
3
H
4
I
3
L
3
K
1
M
2
F
1
P
3
S
0
T
1
W
4
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 1 C: 1 E: 1 Q: 2 G: 1 H: 3 I: 4 L: 3 K: 3 M: 1 F: 2 P: 1 S: 3 T: 0 W: 1 Y: 4 V: 0
Chemical Descriptors
34 reviewed residue count
C204H303N55O48S2 sequence-only estimate (linear, free termini)
4358.11 sequence-only estimate (linear, free termini)
9.95 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
1.93 sequence-only estimate (linear, free termini)
-0.585 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0